Albumin-bound Paclitaxel (ab-pac) Versus Docetaxel for First-line Treatment of Metastatic Breast Cancer (MBC): Overall Survival (OS) Subset Analyses of a Randomized Phase 2 Trial

作者:Gradishar W J; Krasnojon D A; Cheporov S V; Makhson A N; Manikhas G M; Clawson A; Bhar P
来源:European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, 2011-09-23 to 2011-09-27.